Personalized Medicine and Bladder Cancer with Dr. Matthew Milowsky – Episode 8
Published on:
Host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.
In Episode 8 of “Bladder Cancer Matters,” host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment.
Dr. Milowsky is the Section Chief, Genitourinary Oncology; Co-Director, Urologic Oncology Program University of North Carolina School of Medicine. Dr. Milowsky is also the chair of the Bladder Cancer Genomics Consortium.
In this episode, Rick and Dr. Kamat discuss:
What the Bladder Cancer Genomics Consortium is and what it does
What an “exceptional responder” is is bladder cancer
The importance of clinical studies to the future of bladder cancer
How philanthropy propels bladder cancer medical research
